Tech & Science
The research was published Oct. 14 in the journal Science Translational Medicine. The paper is titled Loss of GPR3 reduces the amyloid plaque burden...
Hi, what are you looking for?
The research was published Oct. 14 in the journal Science Translational Medicine. The paper is titled Loss of GPR3 reduces the amyloid plaque burden...
Phase three drug trials The pharmaceutical company Eli Lily is set to announce the results of its most recent trials of Solanezumab at the...
Cancer drug fights dementia Developed by the British pharmaceutical giant Astra Zeneca, saracatinib, also called AZDO5030, did not prove effective in trials in fighting...